Everyone says they need AI, but most aren’t ready — the hard part isn’t the model, it’s the messy middle that makes it work.

Jason Morros has spent more than 25 years connecting businesses to consumers across industries including hospitality, travel, ...

With Netflix stock down more than 20% since the transaction was first announced in December, NFLX now prices in substantial deal friction. Read why NFLX is a Buy.

Q4 2025 Earnings Call February 25, 2026 8:30 AM ESTCompany ParticipantsAleksey Lakchakov - Senior Director of Finance & Head ...

Discover the real challenges behind white label crypto exchange development in 2026. From liquidity to compliance, we explore the bottlenecks and how to fix them.

More than 300 workers at Whirlpool Corp.'s manufacturing facility in Amana will lose their jobs March 9, according to union ...

Democrats sent a letter urging the company to reconsider the planned 300-plus layoffs, while Gov. Kim Reynolds said her administration will work to help impacted Iowans ...

New Reporting Tools Provide Documentation to Challenge Low ACV Offers, Total Loss Valuations and Diminished Value Gaps ...

As MWC Barcelona 2026 prepares to host the vanguard of the digital economy, the central challenge for the enterprise sector has shifted from AI ...

Built by veterans of cyber operations, Astelia is the next evolution of exposure management, pinpointing the few vulnerabilities that pose real risk and delivering clear, environment-specific ...

A 91-year-old man with a history of bladder carcinoma and left total knee arthroplasty was evaluated because of left knee pain. A culture of synovial fluid showed no growth. A diagnosis was made.

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and ...